Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25443246 | 0.84 | CCR1 (0.43) | CCR1KMT2ACHRM3EPHX2MEN1 | |
| SCHEMBL25443244 | 0.84 | CCR1 (0.43) | CCR1KMT2ACHRM3EPHX2MEN1 | |
| SCHEMBL25442293 | 0.81 | CCR1 (0.49) | CCR1KMT2ACHRM3EPHX2MEN1 | |
| SCHEMBL25442295 | 0.81 | CCR1 (0.49) | CCR1KMT2ACHRM3EPHX2MEN1 | |
| SCHEMBL25442292 | 0.74 | CCR1 (0.53) | CCR1TRPV1EPHX2 | |
| SCHEMBL25442294 | 0.74 | CCR1 (0.53) | CCR1TRPV1EPHX2 | |
| SCHEMBL25443129 | 0.70 | MAPT (0.35) | KMT2ATRPV1CHRM3MEN1 | |
| SCHEMBL25443110 | 0.70 | MAPT (0.35) | KMT2ATRPV1MEN1 | |
| SCHEMBL25443139 | 0.70 | CCR1 (0.50) | CCR1KMT2ACHRM3MEN1 | |
| SCHEMBL23903537 | 0.67 | CCR1 (0.50) | CCR1KMT2ATRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142739-A1 | PROTEIN-PROTEIN INTERACTION STABILIZERS | UNIV CALIFORNIA (US) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142739-A1 | PROTEIN-PROTEIN INTERACTION STABILIZERS | HSPBP1, HSPA8, HSPH1 | CCR1 4742/4885KMT2A 3385/4885TRPV1 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.